Treatment News : Researchers Discover How HIV Binds to Dendritic 'Carrier' Immune Cells

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » January 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

January 4, 2013

Researchers Discover How HIV Binds to Dendritic 'Carrier' Immune Cells

Scientists have identified the precise protein on the surface of dendritic immune cells that HIV binds to in order to gain entry, and the discovery could lead to the development of new antiretroviral agents that, for the first time, would attack HIV outside of its life cycle within CD4 cells, ScienceDaily reports. Responsible for prompting immune response in CD4 cells, dendritic cells are also known as carrier cells. In the case of HIV, the virus invades the cell, which then spreads it to CD4s.

Researchers from the AIDS Research Institute IrsiCaixa published a paper in the open access journal PLOS Biology about their discovery of a protein called Siglec-1 that’s on the surface of dendritic cells. Siglec-1 binds to what are known as gangliosides on HIV’s surface and thus help transmit more of the virus to CD4s.

In a lab setting, the researchers combined HIV with varying quantities of Siglec-1 and discovered that higher levels of the protein improved the dendritic cells’ capacity to capture HIV, which then led to greater transmission of the virus into CD4 cells. The scientists also found that inhibiting Siglec-1 prevented dendritic cells from capturing the virus, indicating that such inhibition may be an effective aim for a future drug therapy.

For the study abstract, click here.

To read the ScienceDaily report, click here.

Search: dendritic cells, Siglec-1, AIDS Research Institute IrsiCaixa, PLOS Biology


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    Hillcrester
    Ramona
    California


    soy_Ric
    Rochester
    New York


    Heartland4now
    Tacoma
    Washington


    jacob2608
    Panama City Beach
    Florida
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Do you enjoy books with HIV-positive characters?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.